See also this year's filing and all EDGAR filings for this company.
PDF Report 0001012477_2016_Avadel_Pharmaceuticals_PLC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001012477, Avadel Pharmaceuticals PLC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 166,306,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 34,316,000 |
| 2 | PropertyPlantAndEquipmentNet | 2,616,000 |
| 3 | remainder_Assets | 11,739,000 |
| 4 | LiabilitiesCurrent | 48,788,000 |
| 5 | LiabilitiesNoncurrent | 2,894,000 |
| 6 | remainder_Liabilities | 95,430,000 |
| 7 | CostOfGoodsAndServicesSold | 10,921,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 21,712,000 |
| 9 | ResearchAndDevelopmentExpense | 25,608,000 |
| 10 | remainder_Expenses | 87,554,000 |
| 11 | remainder_Revenues | 173,209,000 |
| 12 | remainder_NetIncome | 13,245,000 |
| 13 | remainder_ComprehensiveNetIncome | -15,234,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 214,977,000 |
| 1 | Liabilities | 147,112,000 |
| 2 | Expenses | 145,795,000 |
| 3 | Revenues | 173,209,000 |
| 4 | StockholdersEquity | 67,865,000 |
| 5 | NetIncome | 40,659,000 |
| 6 | ComprehensiveNetIncome | 33,042,000 |
| 7 | BaseVar | 354,786,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.000 |
| 9 | EconomicCapitalRatio | 2.30 |
Edgar->Model Mapping
Feature Distribution
